The pharmaceutical industry's increasing scale and influence means that no part of its conduct is above scrutiny, and criticism of …
Pfizer is looking to sell off about 60 non-core consumer products in Europe to position the business for long-term growth …
Sanofi-Synthelabo's Eloxatin has received US approval for use as first line treatment of colorectal cancer in combination with standard treatment …
Independent marketing communications agency Ware Anthony Rust has consolidated its healthcare accounts into a new division prompted by the sector's …
Genzyme, one of the US' most successful biotechnology companies has chosen Cambridge as the location of its first research centre …
A number of states and cities are drawing up plans to import medicines from Canada in open defiance of the …
New bodies intended to give patients and the public a greater say in their local health service have been launched …
AstraZeneca's new blockbuster candidate Exanta has been approved in France for the prevention of blood clots in major orthopaedic surgery.The …
The performance indicators used to calculate the star ratings of trusts in England have been given a major overhaul following …
Debt-laden Irish pharma company Elan has sold its European sales and marketing business to Medeus – a new pharma company …
The final details of the new general medical services (GMS) contract have been agreed by the government, PCT and doctors' …
As healthcare consumers take more responsibility for their health, analysts predict the dynamic between the traditional pharma sales force, healthcare …
Pfizer has criticised new UK guidance advising doctors that Prozac is the only SSRI anti-depressant safe to prescribe to children.The …
Indebted Irish pharmaceutical company Elan has confirmed that it is in talks to sell part of its European operations.The company …